iBio (IBIO) Change in Account Payables (2010 - 2026)
iBio's (IBIO) quarterly Change in Account Payables came in at $380000.0 in Q1 2026, down 55.97% year-on-year from $863000.0 in Q1 2025, and up 1410.34% on a QoQ basis from -$29000.0 in Q4 2025.
iBio (IBIO) Change in Account Payables (2010 - 2026) Analysis & Trends
iBio (IBIO) has 17 years of Change in Account Payables data on file, last reported at $380000.0 in Q1 2026.
- On a quarterly basis, Change in Account Payables fell 55.97% year-over-year to $380000.0 in Q1 2026; TTM through Mar 2026 was $1.6 million, a 525.7% increase from a year earlier, with the FY2025 full-year figure at $1.8 million, up 222.8% from the prior year.
- Change in Account Payables for Q1 2026 stood at $380000.0, up from -$29000.0 in the prior quarter.
- Over the last five years, Change in Account Payables for IBIO reached as high as $1.0 million in Q4 2022 and fell as low as -$1.7 million in Q1 2023.
- Historically, Change in Account Payables has averaged $54588.2 across 5 years, with a median of $62000.0 in 2023.
- On a YoY basis, Change in Account Payables climbed as much as 701.61% in 2024 and fell as far as 504.17% in 2024.
- Year by year, Change in Account Payables stood at $1.0 million in 2022, then plunged by 105.04% to -$51000.0 in 2023, then sank by 372.55% to -$241000.0 in 2024, then jumped by 87.97% to -$29000.0 in 2025, then jumped by 1410.34% to $380000.0 in 2026.
- Per Business Quant data, the three most recent Change in Account Payables figures were $380000.0 in Q1 2026, -$29000.0 in Q4 2025, and $495000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,839.48 Bn | 65,839.20 Bn | - | - |
| 2 | Nanobiotix | 1,914.07 Bn | 1,914.01 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 469.68 Bn | 464.89 Bn | 1.35 Bn | -42.19 Mn |
| 5 | Vertex Pharmaceuticals | 122.76 Bn | 115.51 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 70.40 Bn | 61.65 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.88 Bn | 50.69 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn | - |
| 10 | iBio | 164.45 Mn | 164.45 Mn | - | 380,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 380,000.00 |
| Mar 31, 2026 | 380,000.00 |
| Dec 31, 2025 | -29,000.00 |
| Dec 31, 2025 | -29,000.00 |
| Sep 30, 2025 | 495,000.00 |
| Sep 30, 2025 | 495,000.00 |
| Jun 30, 2025 | 712,000.00 |
| Jun 30, 2025 | 712,000.00 |
| Mar 31, 2025 | 863,000.00 |
| Mar 31, 2025 | 863,000.00 |
| Dec 31, 2024 | -241,000.00 |
| Dec 31, 2024 | -241,000.00 |
| Sep 30, 2024 | 497,000.00 |
| Sep 30, 2024 | 497,000.00 |
| Jun 30, 2024 | -870,000.00 |
| Jun 30, 2024 | -870,000.00 |
| Mar 31, 2024 | -632,000.00 |
| Mar 31, 2024 | -632,000.00 |
| Dec 31, 2023 | -51,000.00 |
| Dec 31, 2023 | -51,000.00 |